We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+14.83%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$286M
AUM Growth
+$46.1M
Cap. Flow
+$13.8M
Cap. Flow %
4.81%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$13.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 27.03%
2 Healthcare 16.25%
3 Communication Services 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC
1
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$82.7M 28.91%
1,067,892
IL
2
DELISTED
IntraLinks Holdings Inc.
IL
$77.3M 27.03%
6,490,503
EVDY
3
DELISTED
Everyday Health, Inc.
EVDY
$52.5M 18.35%
4,107,522
TVRD
4
Tvardi Therapeutics
TVRD
$30M
$32.4M 11.33%
74,113
RCKT icon
5
Rocket Pharmaceuticals
RCKT
$376M
$14.1M 4.92%
717,646
MGNI icon
6
Magnite
MGNI
$2.72B
$11.9M 4.18%
+798,381
New +$13.8M
RLOC
7
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$8.1M 2.83%
2,570,395
NRX
8
DELISTED
NEPHROGENEX INC COM
NRX
$6.99M 2.44%
1,052,966

Similar funds

Rho Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Rho Capital Partners held 8 positions worth $286M, up 19% from $240M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners deployed $13.8M of net new capital in Q2 2015, opening 1 new position. Its largest new stake was Magnite: 798,381 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.

  • Rho Capital Partners's largest Q2 2015 buy was Magnite: 798,381 shares worth $11.9M.
  • Rho Capital Partners's ten largest holdings make up 100% of its $286M portfolio in Q2 2015.
  • Rho Capital Partners opened 1 new position and closed 0 in Q2 2015.
  • Rho Capital Partners's portfolio value rose 19% quarter-over-quarter to $286M.

Based on Rho Capital Partners's 13F filing for Q2 2015, filed 3 Aug 2015.